BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12504091)

  • 1. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery.
    Ni J; Chen M; Zhang Y; Li R; Huang J; Yeh S
    Biochem Biophys Res Commun; 2003 Jan; 300(2):357-63. PubMed ID: 12504091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
    Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.
    Zhang Y; Ni J; Messing EM; Chang E; Yang CR; Yeh S
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7408-13. PubMed ID: 12032296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
    Tyagi A; Agarwal C; Agarwal R
    Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.
    Zu K; Ip C
    Cancer Res; 2003 Oct; 63(20):6988-95. PubMed ID: 14583501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
    Zhang M; Altuwaijri S; Yeh S
    Oncogene; 2004 Apr; 23(17):3080-8. PubMed ID: 15048090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
    Singh RP; Agarwal C; Agarwal R
    Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
    Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
    Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways.
    Israel K; Sanders BG; Kline K
    Nutr Cancer; 1995; 24(2):161-9. PubMed ID: 8584452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis.
    Israel K; Yu W; Sanders BG; Kline K
    Nutr Cancer; 2000; 36(1):90-100. PubMed ID: 10798221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique natural antioxidants (NAOs) and derived purified components inhibit cell cycle progression by downregulation of ppRb and E2F in human PC3 prostate cancer cells.
    Bakshi S; Bergman M; Dovrat S; Grossman S
    FEBS Lett; 2004 Aug; 573(1-3):31-7. PubMed ID: 15327971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
    Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
    Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth.
    Carey JL; Sasur LM; Kawakubo H; Gupta V; Christian B; Bailey PM; Maheswaran S
    Mol Endocrinol; 2004 Mar; 18(3):696-707. PubMed ID: 14684851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
    Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
    Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.